Search

Matthew N Morrissette

from Wilmington, DE
Age ~53
Get Report
Also known as:
Matt N Morrissette
Phone and address:
200 S Union St #1, Wilmington, DE 19805
Related to:
Mary J BlanksRobert E Redford, 98Donald C Morrissette, 57Andrew G Morrissette, 55Jessica B Morrissette, 54Starla L Morrissette, 85
Connected to:
Allen M Morrissey, 87Alyce A Morrissey, 83Ava K Morrissey, 36Barbara A Morrissey, 88Barrett D Morrissette, 30Bret W Morriss, 65Carl R Morriss, 65Carolyn S Morrissette, 83Charyl Morrissey, 65Chinaester L Morrissette, 47

Matthew Morrissette Phones & Addresses

  • 200 S Union St #1, Wilmington, DE 19805
  • Richmond, VA
  • Newark, DE
  • Landenberg, PA
  • Claymont, DE
  • New York, NY
  • Norfolk, VA
  • 1800 N Union St, Wilmington, DE 19806

Resumes

Resumes

Matthew Morrissette Photo 1

Marketing

View page
Location:
Dracut, Massachusetts
Industry:
Marketing and Advertising
Work:
Friendly Ice Cream Corporation Jun 2004 - Oct 2011
Manager On Duty
Starbucks Coffee Company Sep 2006 - Dec 2006
Internship Group Leader
Education:
University of New Hampshire - Whittemore School of Business and Economics 2002 - 2007
BS, Business Admn
Matthew Morrissette Photo 2

Independent Recreational Facilities And Services Professional

View page
Location:
Greater Philadelphia Area
Industry:
Recreational Facilities and Services

Publications

Us Patents

Methods For Preparing N-[(Aliphatic Or Aromatic)Carbonyl)]-2-Aminoaetamide Compounds And For Cyclizing Such Compounds

View page
US Patent:
6492553, Dec 10, 2002
Filed:
Aug 4, 1999
Appl. No.:
09/368213
Inventors:
Christopher Hulme - Phoenixville PA
George C. Morton - Collegeville PA
Joseph M. Salvino - Schwenksville PA
Richard F. Labaudiniere - Collegeville PA
Helen J. Mason - Skillman NJ
Matthew M. Morrissette - Pottstown PA
Liang Ma - King of Prussia PA
Marie-Pierre Cherrier - Phoenixville PA
Assignee:
Aventis Pharamaceuticals Inc. - Bridgewater NJ
International Classification:
C07C23102
US Classification:
564129, 540200, 540362, 540504, 540506, 540507, 544354, 544355, 544359, 544360, 544374, 544377, 5483137, 5483335, 560 27, 564155, 564158, 502159, 558441
Abstract:
A method for preparing a N-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.

Thrombin Inhibitors

View page
US Patent:
6610692, Aug 26, 2003
Filed:
Oct 28, 1999
Appl. No.:
09/429741
Inventors:
Philip E. Sanderson - Philadelphia PA
Bruce D. Dorsey - Maple Glen PA
Terry A. Lyle - Lederach PA
Matthew G. Stanton - North Wales PA
Donnette Staas - Lansdale PA
Craig Coburn - Skippack PA
Matthew M. Morrissette - Pottstown PA
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
A61K 31497
US Classification:
514248, 544405, 544236, 51425505, 514300, 514303, 514337, 514338, 514339, 546113, 546117, 546118, 546119, 546122, 5462684, 5462721, 5462734, 5462757, 5462771, 5462774
Abstract:
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: or a pharmaceutically acceptable salt thereof, wherein b is NY or O; c is CY or N; d is CY or N; e is CY or N; f is CY or N; g is CY or N; Y , Y , and Y are independently hydrogen, C alkyl, or halogen; Y and Y are independently hydrogen, C alkyl, C cycloalkyl, halogen, NH , OH or C alkoxy, and Y is hydrogen, C alkyl, C cycloalkyl, halogen, âCN, NH , OH or C alkoxy; A is and W, W , R , R , R , R , X and Z are defined in the specification.

Hiv Integrase Inhibitors

View page
US Patent:
7619086, Nov 17, 2009
Filed:
Mar 4, 2005
Appl. No.:
10/591914
Inventors:
Matthew M. Morrissette - Radnor PA, US
Peter D. Williams - Harleysville PA, US
John S. Wai - Harleysville PA, US
Thorsten E. Fisher - Hatfield PA, US
Terry A. Lyle - Lederach PA, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D 221/18
C07D 221/22
A01N 43/40
A61K 31/435
US Classification:
546 26, 514277
Abstract:
Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication:.

Hiv Integrase Inhibitors

View page
US Patent:
20070179196, Aug 2, 2007
Filed:
Mar 9, 2005
Appl. No.:
10/587682
Inventors:
Wei Han - West Chester PA, US
Melissa Egbertson - Ambler PA, US
John Wai - Harleysville PA, US
Linghang Zhuang - Chalfont PA, US
Rowena Ruzek - North Wales PA, US
Debra Perlow - East Greenville PA, US
Richard Isaacs - Harleysville PA, US
Mark Cameron - Brick NJ, US
Bruce Foster - Scoth Plains NJ, US
Ulf Dolling - Westfield NJ, US
R. Hoermer - Westfield NJ, US
Vanessa Obligado - Oreland PA, US
Lou Neilson - Sellersville PA, US
Boyoung Kim - Lansdale PA, US
Linda Payne - Lansdale PA, US
Matthew Morrissette - Radnor PA, US
Peter Williams - Harleysville PA, US
Philip Pye - Guttenberg NJ, US
Remy Angelaud - Union NJ, US
Danny Mancheno - Rego Park NY, US
David Askin - Warren NJ, US
International Classification:
A01N 37/08
US Classification:
514530000
Abstract:
Hydroxy (tetra- or hexa-)hydronaphthyridine dione compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: (I) wherein a, R,1?, R,2?, R,3?, R,4? and R,5? are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

Substituted (Aryl, Heteroaryl, Arylmethyl Or Heteroarylmethyl) Hydroxamic Acid Compounds

View page
US Patent:
60573694, May 2, 2000
Filed:
Sep 12, 1997
Appl. No.:
8/928943
Inventors:
Robert D. Groneberg - Collegeville PA
Kent W. Neuenschwander - Schwensville PA
Stevan W. Djuric - Libertyville IL
Gerald M. McGeehan - Chester Springs PA
Christopher J. Burns - Rosemont PA
Steven M. Condon - Chester Springs PA
Matthew M. Morrissette - Pottstown PA
Joseph M. Salvino - Schwenksville PA
Anthony C. Scotese - King of Prussia PA
John W. Ullrich - Schwenksville PA
Assignee:
Rhone-Poulenc Rorer Pharmaceuticals Inc. - Collegeville PA
International Classification:
A01N 3728
US Classification:
514575
Abstract:
This invention is directed to compounds of formula I: ##STR1## wherein the variables are as described herein. Compounds within the scope of the present invention possess useful properties, more particularly pharmaceutical properties. They are especially useful for inhibiting the production or physiological effects of TNF in the treatment of a patient suffering from a disease state associated with a physiologically detrimental excess of tumor necrosis factor (TNF). Compounds within the scope of the present invention also inhibit cyclic AMP phosphodiesterase, and are useful in treating a disease state associated with pathological conditions that are modulated by inhibiting cyclic AMP phosphodiesterase, such disease states including inflammatory and autoimmune diseases, in particular type IV cyclic AMP phosphodiesterase. Compounds within the scope of the present invention may also inhibit an MMP, and are useful in treating a disease state associated with pathological conditions that are modulated by inhibiting MMPs, such disease states involve tissue breakdown and those associated with a physiologically detrimental excess of TNF. The present invention is therefore also directed to the pharmaceutical use of the compounds, pharmaceutical compositions containing the compounds, intermediates leading thereto and methods for the preparation of the compounds and their intermediates.
Control profile
Matthew N Morrissette from Wilmington, DE, age ~53 Get Report